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Abstract
Prokineticin	receptors,	PKR1	and	PKR2	(provisional	nomenclature	as	recommended	by	NC-IUPHAR	[23])
respond	to	the	cysteine-rich	81-86	amino-acid	peptides	prokineticin-1	(also	known	as	endocrine	gland-derived
vascular	endothelial	growth	factor,	mambakine)	and	prokineticin-2	(protein	Bv8	homologue).	An	orthologue	of
PROK1	from	black	mamba	(Dendroaspis	polylepis)	venom,	mamba	intestinal	toxin	1	(MIT1,	[65])	is	a	potent,
non-selective	agonist	at	prokineticin	receptors	[41],	while	Bv8,	an	orthologue	of	PROK2	from	amphibians
(Bombina	sp.,	[44]),	is	equipotent	at	recombinant	PKR1	and	PKR2	[48],	and	has	high	potency	in	macrophage
chemotaxis	assays,	which	are	lost	in	PKR1-null	mice.
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